X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Search Again

We support boolean queries, use +,-,<,>,~,* to alter the weighting of terms

Showing 20 out of 29,157 Resources on page 745

dcGO

A database of domain-centric ontologies on functions, phenotypes, diseases and more. As a biomedical ontology resource, dcGO integrates functional, phenotypic, disease, and drug information. As a protein domain resource, it includes annotations to both the individual domains and supra-domains. Domain classifications and ontologies are organized in hierarchies, and dcGO includes the facility to browse the hierarchies: SCOP Hierarchy for browsing domains, GO Hierarchy for browsing GO terms, and BO Hierarchy for browsing other terms (mostly phenotypes). Users can mine and browse through resources.

  • Resource
  • SciCrunch
  • 11 years ago - by Anonymous

anti-tRFP antibody

Evrogen #AB233

  • Resource
  • SciCrunch
  • 11 years ago - submitted by Yosuke Tanaka

C57Bl6/NCrl

WT Control C57BL6/NCrl mice from Charles River.

  • Resource
  • SciCrunch
  • 11 years ago - submitted by Kelly Barford

Molecular Dynamics Workflow (BioKepler)

A workflow for running molecular dynamics simulations. It can be used for all-atom molecular dynamic simulations, which involve five steps of minimization, one step of heating, three steps of equilibration, and one or more instances of production. The input is a set of directories that include the MD simulation input scripts, system topology and coordinate files. Output files are list of plots, simulation trajectories, intermediate files, restart files, and the like.

  • Resource
  • SciCrunch
  • 11 years ago - submitted by Robert Malmstrom

Teen-Longitudinal Assessment of Bariatric Surgery

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on June 29,2023. Consortium made up of five clinical centers and a data coordinating center. The goal of Teen-LABS is to conduct clinical, epidemiological, and behavioral research in adolescent bariatric surgery, through an observational prospective study protocol. Teen-LABS is an ancillary study to LABS, an observational study of adult bariatric surgery. Research staff, certified in standardized uniform data collection according to the protocol, collect data at pre-operative research visits, at surgery, 30 days and six months post-operative, and annual post-operative research visits at the five participating centers.

  • Resource
  • dkNET
  • 11 years ago - submitted by Ko-Wei Lin

Integrated Islet Distribution Program (IIDP)

The goal of the Integrated Islet Distribution Program (IIDP) is to work with the leading islet isolation centers in the U.S. to distribute high quality human islets to the diabetes research community, in order to advance scientific discoveries and translational medicine.

  • Resource
  • dkNET
  • 11 years ago - submitted by Ko-Wei Lin

Assessment Serial Evaluation and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI)

A study which recruits patients with and without an episode of acute kidney injury during a hospitalization, and follows them longitudinally for major cardiac, renal and mortality events. An important aspect of the study is the prospective evaluation of potential biomarkers for renal and cardiac outcomes.

  • Resource
  • dkNET
  • 11 years ago - submitted by Ko-Wei Lin

Clinical Islet Transplantation Consortium (CITC)

Network of clinical centers and a data coordinating center established to conduct studies of islet transplantation in patients with type 1 diabetes.

  • Resource
  • dkNET
  • 11 years ago - submitted by Ko-Wei Lin

Glycemic Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

A comparative study that aims to determine which combination of two medications is best for glycemic control in Type 2 Diabetes, has the fewest side effects, and is the most beneficial for overall health. GRADE is a randomized clinical trial of participants diagnosed with type 2 diabetes within the past 10 years who are already on metformin. Participants will be randomly assigned to 1 of 4 commonly-used glucose-lowering drugs (glimepiride, sitagliptin, liraglutide, and basal insulin glargine), plus metformin, and will be followed for up to 7 years.

  • Resource
  • dkNET
  • 11 years ago - submitted by Ko-Wei Lin

Restoring Insulin Secretion Consortium (RISE)

Consortium which includes 3 studies, each assessing the hypothesis that aggressive glucose lowering will lead to recovery of beta-cell function that will be sustained after treatment in those with prediabetes and early type 2 diabetes.

  • Resource
  • dkNET
  • 11 years ago - submitted by Ko-Wei Lin

Vitamin D to Prevent Type 2 Diabetes (D2d)

A study to determine whether vitamin D supplementation is safe and effective in delaying the onset of type 2 diabetes in people at risk for the disease and to gain a better understanding of how vitamin D affects glucose metabolism.

  • Resource
  • dkNET
  • 11 years ago - submitted by Ko-Wei Lin

CKD Biomarkers Consortium

A consortium which aims to promote the discovery and validation of biomarkers to advance the field of CKD research. The NIDDK CKD Biomarkers Consortium brings together investigators whose expertise includes clinical nephrology, epidemiology, molecular biology, genomics, proteomics, metabolomics, systems biology, laboratory medicine, biostatistics, and laboratory test verification and qualification.

  • Resource
  • dkNET
  • 11 years ago - submitted by Ko-Wei Lin

Nephrotic Syndrome Study Network (NEPTUNE)

A consortium of researchers conducting a cohort study that investigates the underlying disease mechanisms of pro non-inflammatory glomerular diseases. The aim is to elucidate pathogenesis and identify therapeutic targets for clinical trials. The study participants will be classified according to the kidney biopsy results into one of three subcohorts, including Minimal change disease/Focal segmental glomerulosclerosis; Membranous nephropathy; and other conditions.

  • Resource
  • dkNET
  • 11 years ago - submitted by Ko-Wei Lin

Porphyria Consortium

A consortium which includes five of the leading porphyria centers in the United States that provide expertise and experience in the diagnosis and treatment of patients with porphyria. The staff in each Center includes porphyria physicians, researchers, research coordinators, and technical/laboratory staff. Together with the American Porphyria Foundation, the Porphyrias Consortium enables a large scale collaborative effort to develop strategies and methods for diagnosis, treatment, and prevention of illness and disability resulting from these rare disorders.

  • Resource
  • dkNET
  • 11 years ago - submitted by Ko-Wei Lin

Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN)

A research consortium with the long term goal of developing and testing measurement tools to describe symptoms of lower urinary tract dysfunction (LUTD) in women and men. The group plans to study targeted populations of patients with LUTD in order to expand our understanding of the causes of symptoms and common ways that symptoms change over time. The researchers will also collect biosamples from patients for current and future study of LUTD.

  • Resource
  • dkNET
  • 11 years ago - submitted by Ko-Wei Lin

Hyperglycemia and Pregnancy Outcomes Follow-Up Study Consortium (HAPO-FUS)

The goal of this follow-up study of mothers who participated in the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study is to determine the levels of blood sugar during pregnancy that are linked to increased body fat in the child, as well as to determine the chances of a mother developing diabetes 8-12 years after the pregnancy. The original study examined 23,316 mother-child pairs, and researchers determined that the hyperglycemia of a mother was linked to newborn birth weight and body fat. HAPO-FUS will enroll 7,000 or the original HAPO mother-child pairs for one follow-up visit to assess body composition, blucose metabolism, medical history, and other metabolic parameters.

  • Resource
  • dkNET
  • 11 years ago - submitted by Ko-Wei Lin

Lifestyle Interventions for Expectant Moms (LIFE-Moms)

A consortium whose overall goal is to identify effective behavioral and lifestyle interventions that will improve weight, glycemic control and other pregnancy-related outcomes in obese and overweight pregnant women, and determine whether these interventions reduce obesity and metabolic abnormalities in their children. The study/consortium is comprised of seven clinical centers, with each clinical center conducting its own trial. Additional information on the consortium and individual trials is located in the Consortium Summaries tab.

  • Resource
  • dkNET
  • 11 years ago - submitted by Ko-Wei Lin

Multi-Disciplinary Approach to the Study of Chronic Pelvic Pain

Collaborative research network specializing in urological chronic pelvic pain disorders. Project involves conducting research primarily on interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome and involves researchers from multiple disciplines. MAPP Network includes researchers with clinical, epidemiological, and basic research expertise.

  • Resource
  • dkNET
  • 11 years ago - submitted by Ko-Wei Lin

Predicting Response to Standardized Pediatric Colitis Therapy (PROTECT)

A study of how children newly diagnosed with ulcerative colitis (UC) respond to mesalamine and prednisone (corticosteroid), the standard initial therapies used to treat this disorder. Over a period of 5 years PROTECT will prospectively study the course of 430 children newly diagnosed with UC who are treated with standardized care. Biospecimens (blood, stool, colonic biopsy tissue) will be obtained and used to better understand the effects of genetics, mechanisms of inflammation, Vitamin D, and the bacteria contained in the stool (microbiome) on clinical outcomes.

  • Resource
  • dkNET
  • 11 years ago - submitted by Ko-Wei Lin

Action to Control Cardiovascular Disease Risk in Diabetes Follow-up Study (ACCORDION)

A prospective, observational follow-up study of at least 8000 participants who were treated and followed in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. Treatment in ACCORD ended in 2009 and ACCORDION is designed to further elucidate the long-term effects of the ACCORD treatment strategies and provide additional data on the relationships among various cardiovascular and diabetic risk factors.

  • Resource
  • dkNET
  • 11 years ago - submitted by Ko-Wei Lin